[HTML][HTML] Individualized antibiotic dosage regimens for patients with augmented renal clearance

AX Shi, Q Qu, HH Zhuang, XQ Teng, WX Xu… - Frontiers in …, 2023 - frontiersin.org
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function
commonly observed in 30%–65% of critically ill patients despite normal serum creatinine …

[HTML][HTML] Pharmacokinetics of antibacterial agents in the elderly: the body of evidence

OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Infections are important factors contributing to the morbidity and mortality among elderly
patients. High rates of consumption of antimicrobial agents by the elderly may result in …

Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?

TMJ Ewoldt, S Bahmany, A Abdulla… - Journal of …, 2023 - academic.oup.com
Background Standard antibiotic dosing is not suitable for critically ill patients, due to altered
pharmacokinetics (PK) in these patients. Knowledge of protein binding is important for …

Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis

G An, CB Creech, N Wu, RL Nation, K Gu… - Antimicrobial agents …, 2023 - Am Soc Microbiol
In the present study, population pharmacokinetic (PK) analysis was performed based on
meropenem data from a prospective study conducted in 114 critically ill patients with a wide …

Meropenem pharmacokinetics and target attainment in critically ill patients

Y Gan, X Meng, N Lei, H Yu, Q Zeng… - Infection and Drug …, 2023 - Taylor & Francis
Purpose This study aimed to investigate the pharmacokinetics and target attainment of
meropenem and compare the effect of meropenem dosing regimens in critically ill patients …

[HTML][HTML] Predicting Beta-Lactam Target Non-Attainment in ICU Patients at Treatment Initiation: Development and External Validation of Three Novel (Machine Learning …

A Wieringa, TMJ Ewoldt, RN Gangapersad, M Gijsen… - Antibiotics, 2023 - mdpi.com
In the intensive care unit (ICU), infection-related mortality is high. Although adequate
antibiotic treatment is essential in infections, beta-lactam target non-attainment occurs in up …

Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

J Hansel, F Mannan, R Robey… - JAC-Antimicrobial …, 2024 - academic.oup.com
Introduction Population pharmacokinetic studies of β-lactam antimicrobials in critically ill
patients derive models that inform their dosing. In non-linear mixed-effects modelling …

Population pharmacokinetics/pharmacodynamics and clinical outcomes of meropenem in critically ill patients

A Boonpeng, S Jaruratanasirikul… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
Several pathophysiological changes can alter meropenem pharmacokinetics in critically ill
patients, thereby increasing the risk of subtherapeutic concentrations and affecting …

Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia

R Rohani, MH Scheetz, HK Donnelly… - Journal of …, 2022 - academic.oup.com
Objectives Critical illness reduces β-lactam pharmacokinetic/pharmacodynamic (PK/PD)
attainment. We sought to quantify PK/PD attainment in patients with hospital-acquired …

Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study

E Helset, V Cheng, H Sporsem… - Acta …, 2024 - Wiley Online Library
Background Several studies report lack of meropenem pharmacokinetic/pharmacodynamic
(PK/PD) target attainment (TA) and risk of therapeutic failure with intermittent bolus infusions …